[Biomarker and imaging of Alzheimer's disease].
Kawarabayashi
Takeshi
T
Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.
Shoji
Mikio
M
D000544:Alzheimer Disease / Q000175:diagnosis*; D016229:Amyloid beta-Peptides / Q000032:analysis* / Q000134:cerebrospinal fluid; D016564:Amyloid beta-Protein Precursor / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D001921:Brain / Q000000981:diagnostic imaging* / Q000473:pathology; D001923:Brain Chemistry / Q000502:physiology; D003545:Cysteine / Q000031:analogs & derivatives; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D008279:Magnetic Resonance Imaging; D015609:Organotechnetium Compounds; D058225:Plaque, Amyloid / Q000378:metabolism; D019275:Radiopharmaceuticals; D015899:Tomography, Emission-Computed, Single-Photon; D016875:tau Proteins / Q000032:analysis* / Q000134:cerebrospinal fluid
D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D015415:Biomarkers; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; D016875:tau Proteins; C059659:technetium Tc 99m bicisate; D003545:Cysteine